QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
Robert Michalik
Advertisement
Robert Michalik is advisor (Quality and Corporate Compliance) at Shabas Solutions LLC.
Articles by Robert Michalik
QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
3
Choosing a Connected Product Technology for Anticounterfeiting
4
Investing in Protecting Pharma Products
5